A strong brand heritage, a more attractive product and smarter marketing is driving the success of the Similasan eye-care brand following its recent relaunch into the Netherlands, according to Harm-Jan Schuurman, head of the Swiss homoeopathic firm’s Dutch subsidiary.
Speaking exclusively to OTC bulletin, Schuurman pointed out that the firm had combined these three elements to establish itself as a top-five player in the eye-care category with a 10% share, following the return of its Similasan Oogdruppels Nr.1 and Nr.2 eye drops to the Dutch market in 2014 after a two-year absence.
